FELICITEX THERAPEUTICS INC has a total of 28 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BETA CAT PHARMACEUTICALS LLC, POLA PHARMA INC and SELAMINE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 2 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | Israel | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Mexico | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials | |
#5 | Electrotherapy | |
#6 | Measuring microorganism processes | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Vilenchik Maria | 22 |
#2 | Frid Michael | 20 |
#3 | Kuznetsova Alexandra | 19 |
#4 | Duey Marc | 16 |
#5 | Gankin Yuriy | 16 |
#6 | Alexandra Kuznetsova | 4 |
#7 | Michael Frid | 4 |
#8 | Maria Vilenchik | 4 |
#9 | Yuriy Gankin | 4 |
#10 | Marc Duey | 4 |
Publication | Filing date | Title |
---|---|---|
US2018179199A1 | Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases | |
AU2017248807A1 | Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis | |
CN109562176A | Use the combination for being used to treat tumour of akinete targeting and EGFR inhibitor | |
EP2999698A1 | Treatment of cancer by targeting quiescent cancer cells |